> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Abraxis Drug Not Withdrawn Due to Safety/Efficacy
- URL: https://www.fdaweb.com/abraxis-drug-not-withdrawn-due-to-safety-efficacy/
- Published: 2021-05-25T12:00:00.000Z
- Updated: 2026-09-14T17:00:24.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149393

*Federal Register* notice: FDA has determined that Abraxis Pharmaceutical’s injectable manganese sulfate 0.1 mg/mL was not withdrawn due to safety or effectiveness reasons. The determination will allow FDA to approve ANDAs that reference the product if all other legal and regulatory requirements are met. The drug is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-05-25/pdf/2021-11021.pdf?ref=fdaweb.com).